TY - GEN AU - Fenn,Chris G TI - Cost-effectiveness findings not based on available evidence SN - 0025-729X PY - 2004///1108 KW - Anti-Inflammatory Agents, Non-Steroidal KW - adverse effects KW - Cost-Benefit Analysis KW - Cyclooxygenase Inhibitors KW - administration & dosage KW - Drug Costs KW - Drug Industry KW - Evidence-Based Medicine KW - Humans KW - Sensitivity and Specificity KW - United States KW - United States Food and Drug Administration N1 - Publication Type: Comment; Comparative Study; Letter UR - https://doi.org/10.5694/j.1326-5377.2004.tb06307.x ER -